911925
NanoFabTx™ microfluidic chip
for 1-5 μm particles
Synonym(s):
Microfluidic kit, Microparticle, NanoFabTx™, Nanoformulation
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NC.25
UNSPSC Code:
41116105
Product Name
NanoFabTx™ microfluidic chip, for 1-5 μm particles
description
Microfludic hardware kit component for synthesizing 1-5 μm microparticles
Kit components :
application(s)
advanced drug delivery
Quality Level
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
NanoFabTx™ microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric microparticles. NanoFabTx™ microfluidic chip, for 1-5 μm particles can be used as a replacement for the component in our NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles (911860).
General description
NanoFabTx™ microfluidic chip, for 1-5 μm particles is a component of our NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 µm particles (911860). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.
Legal Information
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service